MedPath

Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity

Recruiting
Conditions
Climate Change
Chronic Lung Disease
Air Pollution
Interventions
Other: No intervention
Registration Number
NCT06592235
Lead Sponsor
Hacettepe University
Brief Summary

Climate change is characterized by global temperature increase, melting of glaciers and increasing temperature of ocean waters. Increase in greenhouse gases such as nitrogen and carbon dioxide negatively affects air and water quality. Extreme events such as extreme heat waves, floods and hurricanes are events seen with climate change. It is known that climate change and air pollution have negative effects on public health. Its adverse effects are often seen in individuals with rhinosinusitis, asthma and chronic obstructive pulmonary disease. Air pollution is expected to increase due to the ongoing economic growth and population growth worldwide, resulting in more respiratory diseases and disease burden. This study aims to assess the awareness level of individuals with chronic lung disease on climate change, heat waves, air pollution and their interaction with physical activity and anxiety and depression levels, and to better understand the experiences of patients and learn their perspectives. Within the scope of the study, it is planned to provide patients brief information on this subject and receive feedback about this information.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Individuals with chronic obstructive lung diseaseNo interventionIndividuals with chronic obstructive lung disease
Individuals with asthmaNo interventionIndividuals with asthma
Individuals with bronchiectasisNo interventionIndividuals with bronchiectasis
Individuals with interstitial lung diseaseNo interventionIndividuals with interstitial lung disease
Primary Outcome Measures
NameTimeMethod
Air temperature1 week before other assessments

The air temperature of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).

Humidity level1 week before other assessments

The humidity level of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).

Wind speed1 week before other assessments

The wind speed of the province and district where the patients were located and lived one week before the assessment will be recorded from the open access website of the General Directorate of Meteorology of the Ministry of Environment and Urbanization (https://www.mgm.gov.tr/).

Air pollution1st day

The province and district where the patients were located and lived in the last week before the assessment will be recorded and the air pollutant values of PM2.5, PM10, CO, NO2, SO2, NO, O3 in the settlement where they lived in the last week will be accessed from the open access website of the continuous monitoring center of the Ministry of Environment and Urbanization and will be recorded and used for analysis. (https://sim.csb.gov.tr/STN/STN_Report/StationDataDownloadNew).

Cognitive assessment1st day

Standardized Mini Mental Test. will be used for cognitive assessment. It provides assessment of cognitive activities such as understanding, reading, remembering and performing actions consisting of eleven questions. It is scored between 0-30. \< 18 (quite a lot of cognitive impairment), 18-22 (moderate cognitive impairment), 23-26 (low cognitive impairment), 27-30 (no cognitive impairment).

Anxiety and depression assessment1st day

Hospital Anxiety and Depression Scale (HADS) will be used to assess anxiety and depression. Seven out of a total of 14 questions measure anxiety and seven questions assess depression. The answers are scored in a four-point Likert format and between 0 and 3. The lowest score that patients can get from both subscales is 0, and the highest score is 21.

Assessment of quality of life1st day

The St. George Respiratory Questionnaire (SGRQ) will be used to assess disease-specific quality of life. The SGRQ is a questionnaire consisting of three categories that patients answer themselves, assessing symptoms, activities and the impact of their disease on their daily lives. The questionnaire consists of a total of 76 questions and is scored between zero and 100, with high scores indicating poor health status.

Health literacy assessment1st day

The Rapid Assessment of Adult Health Literacy in Medicine (REALM) scale will be used for health literacy assessment. REALM tests people\'s word recognition and pronunciation skills. It is a word recognition test in which 66 health-related words are given, with the words becoming increasingly more difficult. Patients will be asked to read all of these words out loud in order.

Physical activity assessment1st day

Physical activity level will be assessed using the International Physical Activity Questionnaire (IPAQ) (Short Form). This questionnaire was designed as a short and long form to determine the physical activity and sedentary behavior levels of adults. The IPAQ short form consists of seven questions and provides information on the time spent in vigorous activity, moderate activity and walking activities, as well as the time spent sitting. Higher IPAQ scores reflect greater levels of physical activity. In addition, the step counts of the participants for the last week will be recorded from their smartphones.

Secondary Outcome Measures
NameTimeMethod
Respiratory functions1st day

Respiratory function test values will be recorded from patient records.

Body mass index1st day

Body mass index value will be calculated.

Disease-related symptoms1st day

Disease-related symptoms (shortness of breath, cough and sputum) will be questioned and recorded.

Socio-economic status1st day

Socio-economic status will be recorded.

Education level1st day

Education level will be recorded.

Dyspnea assessment1st day

Modified Medical Research Council (mMRC) dyspnea scale will be used for dyspnea assessment. mMRC dyspnea scale is a scale in which individuals choose the expression that best describes their dyspnea levels from five expressions related to shortness of breath. It easily evaluates shortness of breath due to its simplicity and reliability. Higher mMRC dyspnea scale scores indicate more severe dyspnea (breathlessness).

Charlson Comorbidity Index1st day

Charlson Comorbidity Index (CCI) will be used to query accompanying comorbidities. Higher CCI scores indicate a greater burden of comorbid conditions.

Trial Locations

Locations (1)

Hacettepe University Faculty of Physical Therapy and Rehabilitation

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath